Vaxxinity, Inc. (VAXX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Jul 30, 2026, 4:00 PM EST
Vaxxinity Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| - | - | 0.07 | 0.56 | - | |
Revenue Growth | - | - | -88.15% | - | - |
Cost of Revenue | - | - | 1.94 | 0.05 | - |
Gross Profit | - | - | -1.87 | 0.51 | - |
Selling, General & Admin | 22.39 | 28.35 | 51.83 | 12.22 | 3.01 |
Research & Development | 35.9 | 47.63 | 71.38 | 20.57 | 10.66 |
Operating Expenses | 58.29 | 75.98 | 123.2 | 32.79 | 13.66 |
Operating Income | -58.29 | -75.98 | -125.08 | -32.28 | -13.66 |
Interest Expense | -0.7 | -0.51 | -0.84 | -1.18 | -0.44 |
Interest & Investment Income | 2.09 | 1.26 | 0.01 | 0 | - |
Currency Exchange Gain (Loss) | -0.04 | 0.01 | -0.02 | -0.08 | -0.04 |
Other Non Operating Income (Expenses) | - | - | -8.58 | -6.42 | -0.03 |
EBT Excluding Unusual Items | -56.93 | -75.22 | -134.51 | -39.96 | -14.16 |
Other Unusual Items | - | - | -2.67 | - | - |
Pretax Income | -56.93 | -75.22 | -137.18 | -39.96 | -14.16 |
Income Tax Expense | - | - | - | - | 0.06 |
Net Income | -56.93 | -75.22 | -137.18 | -39.96 | -14.22 |
Net Income to Common | -56.93 | -75.22 | -137.18 | -39.96 | -14.22 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 127 | 126 | 77 | 66 | 34 |
Shares Outstanding (Diluted) | 127 | 126 | 77 | 66 | 34 |
Shares Change | 0.45% | 64.44% | 16.68% | 91.87% | - |
EPS (Basic) | -0.45 | -0.60 | -1.79 | -0.61 | -0.42 |
EPS (Diluted) | -0.45 | -0.60 | -1.79 | -0.61 | -0.42 |
EPS Growth | - | - | - | - | - |
Free Cash Flow | -58.04 | -57.79 | -82.31 | -35.39 | -12.27 |
Free Cash Flow Per Share | -0.46 | -0.46 | -1.07 | -0.54 | -0.36 |
Gross Margin | - | - | - | 90.66% | - |
Operating Margin | - | - | -189507.58% | -5795.69% | - |
Profit Margin | - | - | -207840.91% | -7173.61% | - |
Free Cash Flow Margin | - | - | -124709.09% | -6353.14% | - |
EBITDA | -56.05 | -74.3 | -123.97 | -31.57 | -13.55 |
D&A For EBITDA | 2.23 | 1.68 | 1.1 | 0.72 | 0.11 |
EBIT | -58.29 | -75.98 | -125.08 | -32.28 | -13.66 |